Levofloxacina Alter

Levofloxacin, the active ingredient in Levofloxacina Alter, is a fluoroquinolone presented as a reliable oral tablet for oral use. It treats a range of bacterial infections, including respiratory, urinary, and skin infections, in adult patients when prescribed by a healthcare professional.

GNH USA supplies Levofloxacina Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand across multiple markets. Levofloxacina Alter is exported under controlled conditions, ensuring product integrity from manufacturing to delivery.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary, and skin systems.

- Community‑acquired respiratory tract infection: effective in eradicating susceptible pathogens and improving clinical symptoms. - Urinary tract infection: clears infection by targeting common uropathogens, reducing bacteriuria. - Skin and soft tissue infection: treats cellulitis, abscesses, and wound infections caused by susceptible bacteria. - Acute sinusitis: resolves sinus inflammation by eliminating causative bacterial agents. - Pharyngitis: alleviates sore throat and bacterial load in streptococcal infections. - Chronic bacterial prostatitis: penetrates prostatic tissue to eradicate persistent bacterial infection.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset occurring early in therapy. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient tension‑type headache reported by some patients.

Serious or Rare Side Effects: - Tendon rupture or inflammation: risk of Achilles or other tendon injury, especially with activity. - QT interval prolongation and cardiac arrhythmias: may cause palpitations or syncope in susceptible individuals. - Severe allergic reactions such as Stevens‑Johnson syndrome: rare but potentially life‑threatening skin eruption.

Before prescribing levofloxacin, clinicians should evaluate several safety considerations to minimize risk.

- Renal function: assess and adjust dose in patients with impaired clearance. - History of tendon disorders: avoid use in individuals with prior tendon injury or who engage in high‑impact activities. - Cardiac risk: monitor QT interval in patients with known prolongation or taking other QT‑prolonging drugs. - Concomitant corticosteroids: increased risk of tendon rupture warrants careful monitoring. - Pregnancy and lactation: prescribe only if potential benefit justifies potential fetal or infant risk. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Levofloxacin can interact with other medicines, altering its effectiveness or increasing toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Concurrent fluoroquinolones: additive toxicity, avoid combined use.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Theophylline: levofloxacin can raise serum theophylline concentrations. - Diabetes medications (insulin, sulfonylureas): may cause hypoglycemia; monitor glucose levels.